Minerva Neurosciences, Inc. Recorded Big Gain
Wed, Aug 24, 2022 at 06:54 PM
Minerva Neurosciences, Inc. (NERV:NASDAQ) jumped higher at $7.51, a gain of 66.5%. On Wed, Aug 24, 2022, NERV:NASDAQ touched a New 2-Week High of $7.51. The stock got featured on our News Catalysts scanner on Mon, Aug 22, 2022 at 08:32 AM in the 'BIOTECH' category. From Wed, Aug 10, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About Minerva Neurosciences, Inc. (NERV:NASDAQ)
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.
Top 10 Gainers:
- Minerva Neurosciences, Inc. (NERV:NASDAQ), 66.52%
- SuperCom Ltd. (SPCB:NASDAQ), 62.36%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 48.87%
- Social Capital Suvretta Holdings Corp. I (DNAA:NASDAQ), 48.26%
- AnPac Bio-Medical Science Co., Ltd. (ANPC:NASDAQ), 37.9%
- Riverview Acquisition Corp. (RVAC:NASDAQ), 34.86%
- Gravitas Education Holdings Inc ADR (GEHI:NYSE), 24.83%
- Turquoise Hill Resources Ltd. (TRQ:NYSE), 23.76%
- Golden Sun Education Group Limited (GSUN:NASDAQ), 22.83%
- Farfetch Limited (FTCH:NYSE), 21.3%